论文信息 - Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results - 字舞流文

Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

N. Hayata | M. Ikeda | N. Mizuno | M. Ueno | C. Morizane | F. Nagashima | R. Nakajima | S. Shimizu | H. Ikezawa | Takashi Sasaki